Carclo plc announced that the Board expects the Group to report a marginally stronger underlying operating profit performance in the second half of the financial year subject to any further COVID-19 disruption beyond its current expectation. This reflects higher anticipated CTP product sales from its existing customer base alongside revenues from two new tooling agreements for COVID-19 test components which were entered into during the period with a new medical customer. This is expected to offset a weaker performance in the Aerospace division during the second half due to lower customer demand.